USe of topical corticostEroids in dermatological conditions: Data from Real-world (USER study)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Usage of TCS in atopic dermatitis/eczema and psoriasis by patient subgroups by age.
研究概览
简要总结
Real-world, retrospective, cross sectional, EMR-based study to USe of topical corticostEroids (TCS) in dermatological conditions: Data from Real world (USER study).
The medical records of the patients meeting the eligibility criteria will be taken into consideration.
Patient profiling will be done at the baseline.
Treatment pattern will be evaluate at base line.
As this is retrospective observation EMR based study, study specific patient recruitment is not applicable.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0.10 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with ≥18 years of age diagnosed with psoriasis and prescribed with TCS.
- •Patients diagnosed with atopic dermatitis/eczema and prescribed with TCS.
排除标准
- •Patients with incomplete data with respect to study requirements.
结局指标
主要结局
Usage of TCS in atopic dermatitis/eczema and psoriasis by patient subgroups by age.
时间窗: this is the study where all endpoints will be assessed baseline. The patients on EMR meeting eligibility criteria from 2017 to 2023 will be evaluated
Prescription pattern of TCS prescribed to patients diagnosed with psoriasis and atopic dermatitis/eczema.
时间窗: this is the study where all endpoints will be assessed baseline. The patients on EMR meeting eligibility criteria from 2017 to 2023 will be evaluated
次要结局
- Comorbid conditions & concomitant medications of patients prescribed with TCS for(psoriasis & atopic dermatitis/eczema respectively.)
研究者
B Swathi Reddy
Dr Reddys Laboratories Limited